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DIVERSITY OF THE SYSTEMIC INFLAMMATORY RESPONSE IN NEONATAL SEPSIS.
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A survey of 94 infants of the first week of life was made. The “A” group was presented by newborns who had 
hypoergic variant of sepsis (17 preterm newborns with the gestational age >32 weeks and 11 term newborns). The 
“B” group was presented by newborns who had hyperergic sepsis (16 preterm infants with the gestational age 
>32 weeks and 27 term infants). The group of comparison was comprised by 23 newborns with acute pneumonia. 
The following lab–tests were made: level of 12 acute-phase proteins, IgG, IgM, IgA; levels of STG, TTG, T3, the 
analyses of leukocyte formula, four leukocyte indexes of reactivity.
On the bases of obtained data patterns of 2 lab-clinical variants of the SIRS were suggested. Pattern SIRS 
in hypoergic variant of sepsis is a deficient condition with prevalence of proteases in the spectrum of mediators 
against hypothyroidism of septic genesis. Pattern SIRS in hyperergic variant of sepsis – is a “cytokine storm” with 
maintained hormonal provision of protein-synthetic processes and immunity.
Резюме
К ВОПРОСУ О СИСТЕМНОМ ВОСПАЛИТЕЛЬНОМ ОТВЕТЕ ПРИ НЕОНАТАЛЬНОМ СЕПСИСЕ
Обследовано 94 ребенка первой недели жизни. Группу «А» составили новорожденные с гипоэргиче-
ским вариантом сепсиса (17 недоношенных со сроком гестации >32 недель и 11 доношенных). Группа «В» 
- новорожденные с гиперэргическим вариантом сепсиса (16 недоношенных со сроком гестации > 32 не-
дель и 27 доношенных). Группа сравнения представлена 23 новорожденными с острой пневмонией.
Лабораторное обследование включало определение уровней 12 белков острой фазы, IgG, IgM, IgA, 
уровней СТГ, ТТГ, Т3, анализ лейкоцитарной формулы с определением 4 лейкоцитарных индексов реак-
тивности.
На основании полученных данных было выделено 2 клинико-лабораторных варианта SIRS. 
Характер SIRS при гипоэргическом варианте сепсиса — дефицитное состояние с преобладанием про-
теаз в спектре медиаторов и гипотиреоидизм септического генеза.
SIRS при гиперэргическом варианте сепсиса — это «цитокиновый шторм» с сохранением гормональ-
ного обеспечения процессов белкового синтеза и иммунитета.
Introduction. Systemic inflammatory response 
syndrome-(SIRS) is the pathogenetic basis of sepsis 
[1]. The neonatal SIRS developd in particular immu-
nological status of newborn, birth stress and more often 
in premature i.e. initially immunodeficiency organism.
Years of research in the field of neonatal sepsis led 
us to the conclusion that there are at least 2 variants 
of sepsis. Initially by complex survey of children on 
27 hemostatic parameters we were able to identify 
objective criteria to differentiate two patterns of DIC 
- “decompensated” and “overcompensate” for neona-
tal sepsis [2]. Comparison of these data with the full 
range of clinical and laboratory data made it possible to 
formulate the concept of 2 clinical-laboratory variants 
of neonatal sepsis, “hypoergic” and “hyperergic” [3-5].
The aim of this study was to formulate a pattern 
of 2 clinical-laboratory variants of SIRS in neonatal 
sepsis on the basis of acute phase proteins spectrum, 
immunological parameters, hormonal profile, indixes 
of cellular reactivity. This fact would help to create an 
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appropriate “patterns of blood” in combination with 
the previously formulated pattern of DIC- syndrome. 
Methods. We examined 71 newborns with sepsis oc-
curred in the first week of life in the dynamics of patho-
logical process (from 2 to 14 times). There were 28 chil-
dren with hypoergic variant “A” (17 of them were preterm 
with gestational age > 32 weeks) and 43 with hyperergic 
variant «B" - (including 16 preterm newborns with gesta-
tional age > 32 weeks). Mortality rate in variant “A” was 
63,1% and in variant «B» – 13,7%. A comparison group 
was comprised by infants with neonatal pneumonia - 23 
children. Normative data for all hemostatic parameters 
were obtained and published previously [6].
Research methods included the determination 
of platelet hemostasis: platelet count and assessment 
of their functional activity, studied by two methods: 
microscopic and using aggregometer. Microscopic 
identification was performed by the method of aggre-
gation O’Brein JR (1963) modified by Chumakova 
GN, et al. (1987). As agregants were used ADP (Cal-
biochem Behring Corp.), epinephrine (Calbiochem 
Behring Corp.), ristocetin. To evaluate the dynamic 
properties of the platelet aggregometer “THROM-
LITE 1006” was also used. Platelet counts were de-
termined by two methods: phase-contrast microscopy 
and in some cases with an automatic counter.
All parameters of coagulation hemostasis were 
determined using reagents of Behring company (Ger-
many). Tests of overall coagulation: activated partial 
thromboplastin time (APTT), prothrombin time (PT), 
thrombin time (TT) batroxobin time (BT) were mea-
sured by enzymatic method. The contents of fibrino-
gen (FG), fibronectin (FN), antithrombin III (AT-III), 
C1-inhibitor (C1-IN), a1-antitrypsin (a1-AT), a2-
macroglobulin (a2-MG), a-fetoprotein (a-FP), plas-
minogen (PG) were investigated by direct radial im-
munodiffusion. The level of von Willebrand factor 
(vWF) was determined by agglutination of standard 
lyophilized platelets. The concentrations of FG, II, V, 
VII, VIII, IX, X, XI, XII coagulation factors and pro-
tein C (Prot. C) and high molecular kininogen (CMC) 
were determined by enzymatic method. Determination 
of factor XIII was assessed by stability of the clot in 
the monochloroacetic acid. The content of degradation 
products of fibrin and fibrinogen (FDP) were examined 
by semiquantitative agglutination of staphylococci.
Determination of immunoglobulin in the serum 
was performed by radial immunodiffusion (Mancini 
G. et al., 1965). Circulating immune complexes (CIC) 
were determined by two methods: by precipitation in 
polyethylene glycol-6000 (PEG), and in some chil-
dren by method of Kositskaya AS , et al. (1986) using 
0.025% acetic acid.
Determination of hormone levels (somatotropin- 
growth hormone (GH), thyrotropin- thyroid-stimulat-
ing hormone (TSH), triiodothyronine (T3)) in blood 
plasma were made using reagents of Hema company 
(Moscow), on the basis of technology from Fitzgerald 
International Industries, Inc. (USA).
Determination of circulating blood volume (CBV) 
was produced using circulating blood deficiency indi-
cator (CBDI) of “REC” company. The work of device 
is based on the low-frequency conductometry and 
does not require the introduction of substances into 
the blood, reducing research to 15 minutes.
The measurement of osmolarity was carried out on 
osmometer OMKA 1C-01, on measuring the tempera-
ture of bioliquid freezing.
Absolute and relative content of all white blood 
cell forms was assessed by the standard method. Leu-
kocyte reactivity indixes were calculated: the index of 
the nuclear shift (NSI), leukocytic intoxication index 
(LII), lymphocyte index (LI), as well as proposed by 
us index of immunoreactivity (IIR).
myelocytes + metamyelocytes + stab neutrophils 
NSI = ------------------------------------------------------------------------------------
segmented neutrophils (seg)
lymphocytes + eosinophils lymphocytes
IIR = ------------------------------------ LI = ------------------------------------
monocytes neutrophils
[ 5 promyelocytes + 4 myelocytes + 3 metamyelocytes + 2 stab neutrophils +
segmented neutrophils ] + [plasmocytes + 1] 
LII = --------------------------------------------------------------------------------------------
[ lymphocytes + monocytes] x [eosinophils +1] 
LII proposed by JJ Kalf-Caliph in 1941 is used 
nowadays to evaluate the toxicity of pneumonia and 
infectious diseases. Since it was not designed to ana-
lyze septic condition and there was no promyelocyte 
in the formula, we have modified this formula includ-
ing promyelocytes with coefficient 5.
In total were made: -3195 studies of the functional 
activity of platelets;
-21 340 definitions of the parameters of coagula-
tion hemostasis and proteins of “acute phase”;
-2952 determinations of CIC and the three classes 
of immunoglobulin, 539 determinations of the func-
tional activity of macrophages (NBT-test);
-280 of certain hormones;
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-4725 definitions of CBV and the osmolarity of 
blood plasma;
-17,040 calculated indices of cell reactivity;
The results of all above mentioned studies were 
matched with the whole spectrum of clinical and 
“routine” laboratory data, including life history and 
diseases of parents, condition of the mother during 
pregnancy and childbirth, clinical and laboratory dy-
namics of the present condition in newborn. 
Results. In hypoergic variant “A” gram-negative 
flora dominated: Pseudomonas aeruginosa – in 40%, 
K. pneumoniae - in 33%, Acinetobacter – in 34%, 
E. Coli – in 20%. Only in 6% of patients S. epider-
midis was allocated. In 73% of children Candida 
was seeded. In hyperergic variant «B» S.aureus and 
S.epidermidis were found in 77% of newborns, in 
35,3% - there was a combination with E Coli and 
Kliebsiella. Candida was found 3 times less than in 
variant «A» (22%). Pseudomonas aeruginosa was re-
vealed only in one child (3% of patients) with a «B» 
variant of sepsis.
Contents of 12th acute phase proteins, including 
members of the coagulation cascade and anticoagu-
lants during the height period are shown in the Table 
1. There were differences in the concentration of in-
vestigated proteins: FG, FN, CMC, α2-MG, AT-III, 
VIIIf, PG. Variant «A» had hypocoagulation with sig-
nificantly lower levels of the above proteins, throm-
bocytopenia with low aggregation activity. Variant 
«B» in spite of the current active DIC had high levels 
of these proteins and tendency to a reduce but higher 
level of platelets than variant «A».
A common factor, regardless of sepsis variant, was 
increasing of α1-AT, C1-IN, and von Willebrand fac-
tor (vWF) in 100% of the patients. However, the val-
ues of α1-AT (2.9g/l) and C1-IN (0.62 g/l) at hypoer-
gic variant compared to hyperergic variant (2 1 g/l and 
0 3 g/l, respectively) were significantly higher. Low 
levels of total plasma protein (M±m = 29.2±2.7 g/l), 
its hyperosmolarity (in "A" variant - 309-312 mOsm/l 
and in "B" variant- 298-303 mOsm/l), deficit in blood 
volume (CBV in group "A» -76 5-78 5 ml/kg and in 
«B» -79 7 - 91 5 ml/kg) - also support the abovemen- 
tioned theory. This correlates with a higher and more 
prolonged hypotension (up to 2 weeks) in variant «A» 
which required constant inotropic support. Systolic 
blood pressure in the form «A» was in average 35±4 
mm Hg and in variant "B" – 50.0�7.0 and the hypoten-
sion period was short (2 - 3 days).
Elevated levels of C-reactive protein (CRP) and 
Alpha-1-acid glycoprotein (AGP) or orosomucoid 
(ORM) occurred in both groups but not in all patients 
(ORM - in 91% of children and CRP - in 66% of pa-
tients regardless of the sepsis variant) (see Table 1).
The levels of the IgM and IgA are presented in 
Table 1 and levels of circulating immune complexes 














Age NSI LII IIR LI 
   
1 day of life 0,01-0,37 0,27--3,56 2,14-8,59 0,17-0,63 
2 day of life 0,02-0,40 0,17- 2,85 2,20-8,47 0,21-0,73 
3 day of life 0,01-0,28 0,12- 1,27 1,65-7,80 0,29-0,95 
4 day of life 0,02-0,25 0,09- 1,02 1,85-9,52 0,38-1,27 
5 day of life 0,03-0,34 0,08- 0,84 2,26-8,73 0,48-1,48 
6 day of life 0,03-0,23 0,09- 0,89 2,32-8,82 0,50-1,29 
7 day of life 0,03-0,33 0,07- 0,65 2,56-9,97 0,64-1,81 
8 day of life 0,03-0,33 0,07- 0,71 2,71-10,18 0,64-1,80 
9-15 day of life 0,02-0,33 0,05- 0,57 2,70-10,34 0,68-2,13 
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Figure 1 Blood levels of circulating immune complexes (CIC - left column) and the 
phagocytic activity of leucocytes test with nitro blue tetrazolium (NBT stimulated and 
basal – respectively central and the right column) in healthy newborns (1), in patients 
with neonatal pneumonia (2), with hyperergic variant B (3) and hypoergic variant A (4) 

























       





  Blood levels of hormones: somatotropin (STG), thyrotropin (TSH) and triiodothy-
ronine (T3) for 2 variants of neonatal sepsis. Vatiant "A" - hypoergic and variant "B" 
- hyperergic. TSH and T3 are given in comparable units (mIU/L x 10 and ng/ml x 10)  
  
Figure 1. Blood levels of circulating 
immune complexes (CIC - left column) and 
the phagocytic activity of leucocytes test 
with nitro blue tetrazolium (NBT stimulated 
and basal – respectively central and the 
right column) in healthy newborns (1), in 
patients with neonatal pneumonia (2), with 
hyperergic variant B (3) and hypoergic 
variant A (4) of neonatal sepsis. CIC 
and the NST test data are presented in 
conventional units.
Table 1
Levels of acute phase proteins and immunoglobulins in the blood plasma at the height 










































































































































* Р < 0,05 (differences between the variants of sepsis)
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In the first examination conducted on the 1st-3d 
days of life low levels of IgG were revealed (in group 
“A” in average = 3 7 g/l while in group «B» in aver-
age = 4 4 g/l) that indicates a low level of passive im- 
munity in all children with neonatal sepsis. The lower 
figures in the group «A» probably are associated with 
a greater proportion of preterm infants (60 7%).
If variant «A» (hypoergic) at the height stage there 
was lower IgM, CIC as well as indicators of NBT - test 
both stimulated and basal production of levels of reac-
tive oxygen species. The difference between stimulat-
ed and basal activity characterizes the low «reserve» 
of functional activity. This is consistent with lympho-
penia observed for a long time (up to 1 month), shift 
of leukocyte formula to the promyelocytes in the ab-
sence of metamyelocytes and myelocytes, presence 
of toxic granulation of neutrophils in the absence of 
neutrophilia, often full absence of eosinophils. At the 
same time, the IgA levels were higher and correlated 
with the concentration of α1-AT and vWF. 
In hyperergic variant CIC, IgM levels and func-
tional activity of phagocytes (NBT-test) were initially 
higher and increased over time in a 3-3.5 times cor-
relating with increased levels of monocytes, lympho-
cytes, eosinophils, LI and IIR index.
All 100% of septic patients had hormonal dysfunc-
tion (Figure 2), but its character was different. The 
first determination of hormone levels (1-3 days of 
life) in the group «A» found low values of TSH or 
T3 in 97% of newborns. In group «B» such newborns 
accounted for only 7.8 %. 
Hormonal profile in the height stage of the process 
in hypoergic and hyperergic variants of neonatal sep-
sis were significantly different. None of the patients 
with hyperergic variant had low content of T3. While 
in the hypoergic variant there were registered: 1) the 
syndrome of «low T3» (T3 <1 0 ng/ml, range 0.5-1 
0, TSH is not changed) – in 31.3% of children; 2) the 
central suppression of TSH production (TSH 0 06-0 
47 mIU /l, T3 0 58-0 81 ng/ml) occurred in 47.2% and 
3) low levels of all three hormones (GH,TSH, T3) – in 
18.7% of children. So in hypoergic variant of sepsis in 
the majority of children took place as a dysfunction of 
the pituitary-thyroid system at birth and hypothyroid-
ism of septic origin in the height of SIRS. Reduced 
secretion of TSH may be related with the effect of 
dopamine due to prolonged inotropic support.
Children with hyperergic variant of SIRS were 
characterized by more maturity of the axis hypothala-
mus - pituitary - thyroid gland. Episodes of decreased 
TSH levels (<1.7 mIU/L) without decreasing of T3 
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Figure 1 Blood levels of circulating immune complexes (CIC - left column) and the 
phagocytic activity of leucocytes test with nitro blue tetrazolium (NBT stimulated and 
basal – respectively central and the right column) in healthy newborns (1), in patients 
with neonatal pneumonia (2), with hyperergic variant B (3) and hypoergic variant A (4) 

























       





  Blo d ev ls of hormones: somatot opin (STG), thyrotro in (TSH) an  triiodothy-
ronine (T3) for 2 variants of neonatal sepsis. Vatiant "A" - hypoergic and variant "B" 
- hyperergic. TSH and T3 are given in comparable units (mIU/L x 10 and ng/ml x 10)  
  
Figure 2. Blood levels of 
hormones: somatotropin 
(STG), thyrotropin (TSH) and 
triiodothyronine (T3) for 2 
variants of neonatal sepsis. Vatiant 
«A» - hypoergic and variant «B» - 
hyperergic. TSH and T3 are given 
in comparable units (mIU/L x 10 
and ng/ml x 10) 
Table 2 


















































































* Р < 0,05 (differences between the variants of sepsis)  ** Р < 0,05 (differences between stages of the process)
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hyperergic variant 15.4% of children had elevated 
levels of T3 (more than 2.8 ng/ml). The main feature 
of this variant was a high incidence of resistance to 
growth hormone (GH> 50 ng/ml, range 51 - 135 ng/
ml). It was noted in 65.3% of children with variant 
«B» and only 25 5% in the variant «A». According to 
our data, high content of growth hormone in the early 
stages of sepsis and its progressive reduction over 
time and the increase in T3 level are favorable signs. 
Poor outcome was associated with low levels of all 
the abovementioned hormones.
Blood analysis and leukocyte indexes of reactivity 
are presented in Tables 2 and 3.
Two variants of neonatal sepsis were significantly 
different for quantitative and qualitative composition of 
leukocytes at the beginning of the process. Initially, in 
variant «A» total number of leukocytes was an average 
of 7.3 x 109, nuclear shift (increased NSI) was absent in 
70% of newborns, 91% of children had lymphopenia 
(mean 0 69 x 109). In variant “B” the number of leuko-
cytes at baseline was 23.0 x 109, 67% of children had an 
increased NSI, being regenerative in nature.
At the beginning of the process children in both 
groups were characterized by high LII and low LI and 
IIR, refl ecting lower immune reactivity in which de-
veloped sepsis. In variant «A» initially high was LII 
in 75% of children, LI in 47% of children was below 
norm and IIR was in 46% below norm. 
At the height stage in 100% of children in group 
«A» was marked aneosinophilia (in the form of epi-
sodes from 3 to 11 times and in 21% with lethal out-
come - throughout the disease). Nuclear shift to pro-
myelocytes was detected in 81% of children in variant 
«A» in the background of normal or decreased content 
of neutrophils. Myelocytes and metamyelocytes were 
absent in the blood (ie, there was a «failure» resem-
bling acute myeloid leukemia). Simultaneously there 
was observed toxic granularity in neutrophils. This 
character of NSI was observed for a long time (up to 
38 days of life or death). We decided it was a sign 
of depletion of bone marrow pool reserve of neutro-
phils. A similar shift was observed in the form of a 
single episode in 12.3% of children in group «B». In 
hypoergic variant NSI is not regenerative. Episodes 
of neutropenia were observed in 59% of the children. 
Monocytopenia was observed in 60% of patients 
(mean minimum value was 0.2 x 109). The maximum 
absolute value of the monocytes content was 3.9 x 109.
In hyperergic variant increased or normal level of 
neutrophils was in 81% of children and only 32% of 
children had a single episode of eosinopenia. The ab-
solute content of lymphocytes significantly varied be-
tween episodes of lymphopenia to lymphocytosis (min-
imum values were 1.7 x 109 and the maximum 10.6 x 
109) that is significantly higher than in the group “A”. 
The most informative criterion characterizing the 
different variants of SIRS was a combination of cell 
reactivity indices each of which reflects only a part 
of the process. High levels of LII correlate with the 
severity of endotoxemia but in different variants of 
SIRS it seems to reflect a different qualitative char-
acteristic of the inflammatory mediator spectrum. So 
in sepsis «A» high LII was combined with low IIR 
and in sepsis «B» high LII was combined with a high 
IIR that allowed us to use this feature as a differential. 
LII has revealed differences between the variants in 
absolute values - the value of the index > 3.4 is a char-
acteristic feature of hypoergic variant «A».
Increasing of indixes LI and IIR in favorable dy-
namics of clinical status is a good sign and indicates 
the increase in the relative content of lymphocytes. 
However, LI reflects only the proportion of their con-
tent in relation to the neutrophils. IIR refl ects imbal-
ance of basic cells that produce cytokines and imbal-
ance in the cytokine profile in the presence of lympho-
penia. Deficit of eosinophils means a lack of inflam-
mation antimediators hence the lack of detoxification 
component in the spectrum of mediators.
Thus, the main hallmark of 2 SIRS variants by an-
alyzing criteria is the dynamics of the complex index 
LII, IIR and LI. Each index individually and one-time 
assessment does not allow differentiating the variant 
of SIRS and predicting of trend. NSI in «A» variant 
usually masks low bone marrow reserve.
Table 3 
Standard values for leukocyte index of reactivity
Age NSI LII IIR LI
1 day of life 0,01-0,37 0,27--3,56 2,14-8,59 0,17-0,63
2 day of life 0,02-0,40 0,17- 2,85 2,20-8,47 0,21-0,73
3 day of life 0,01-0,28 0,12- 1,27 1,65-7,80 0,29-0,95
4 day of life 0,02-0,25 0,09- 1,02 1,85-9,52 0,38-1,27
5 day of life 0,03-0,34 0,08- 0,84 2,26-8,73 0,48-1,48
6 day of life 0,03-0,23 0,09- 0,89 2,32-8,82 0,50-1,29
7 day of life 0,03-0,33 0,07- 0,65 2,56-9,97 0,64-1,81
8 day of life 0,03-0,33 0,07- 0,71 2,71-10,18 0,64-1,80
9-15 day of life 0,02-0,33 0,05- 0,57 2,70-10,34 0,68-2,13
1 month 0,02-0,18 0,03- 0,34 4,05-18,14 1,09-3,91
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Pneumonia in the initial stage of the development 
has a number of common features with variant «B», 
however all indexes were within normal limits.
Discussion. Clinical-laboratory variants of SIRS 
in neonatal sepsis are not identified either in Russian 
or foreign literature. However, there were attempts to 
detect differences in the spectrum of cytokines IL1b, 
IL6, IL8, CSF (colony-stimulating factors) for gram-
positive and gram-negative sepsis, but their results 
were contradictory [7-11]. There is a common opinion 
about the “imbalance” of inflammation mediators, in-
cluding cytokines in sepsis [10, 12-14]. In our opin-
ion, the contradictory of literature data indicates the 
existence of heterogeneity of SIRS and the presence 
of variants associated with both the features of the 
original reactivity and the type of pathogen.
Our data on the initial low concentrations of TSH 
and T3, low content of total protein, IgG in hypoergic 
variant «A» indicate the immaturity of the system hy-
pothalamus - pituitary - thyroid gland at birth and sug-
gest the failure mechanisms of immunological protec-
tion and hormonal support.
The predominance of gram-negative bacteria as the 
causative agents of sepsis in the group «A» requires a 
higher level of endotoxemia. ET leading to a reduction 
of marginalized pool of leukocytes, exposure of vascular 
endothelium triggers the activation of proteolytic cas-
cade systems of the plasma [15]. Our data on the high 
content of α1-AT providing 88% of anti-protease activ-
ity of plasma and C1-IN suppressing contact activation 
of thrombin and kallikrein-kinin system confirmed the 
fact of «proteolytic explosion» in sepsis [15-18]. Ob-
viously in variant «A» there is no appropriate level of 
antimediators in particular due to lack of eosinophils and 
low protein synthetic capacity of the organism.
In hypoergic variant «A» we revealed more pro-
nounced violation of ability of phagocytes to a full 
answer in the NBT-test due to neutropenia. We associ-
ate this fact with higher levels of ET able to activate 
neutrophils with elastase releasing [19], damage cells 
and stimulate apoptosis of neutrophils [19-21] and 
low T3 level [22-24].
Hypothyroidism of septic origin, noted by us only 
in hypoergic variant, consistent with the idea of ET 
damaging effect especially for TSH receptor on thyroid 
follicular cells. Damage of the entire hypothalamic- 
pituitary - thyroid axis in patients who died indicated 
Leon Sans et al [22,25,26]. In general, this variant of 
SIRS can be described as «deficient». It is necessary to 
keep in mind not only the shortage of protein, energy 
deficit and deficit of lymphokines due to lymphopenia 
and the possible shortage of cytokines of monocytic 
origin. There are reports on the limitation of monocytes 
response of preterm children to ET («endotoxin toler-
ance») [27], decreased IL8 production in sepsis [28].
Thus, endotoxicosis in hypoergic sepsis “A” has a 
distinguishing quality characteristic from variant “B”. 
This is evidenced not only by differences in the spec-
trum of acute phase proteins, but also analysis of the 
complex indixes of cell reactivity we used.
Children with hyperergic variant did not have 
marked signs of thyroid function depression either at 
baseline or during the septic process. Among the caus-
ative agents gram-positive flora dominated so we could 
expect a stimulating influence of the staphylococcal 
enterotoxin as superantigen on the proliferation of lym-
phocytes and their contribution to the corresponding 
hypercytokinemia and toxemia. However, we believe 
that in this variant of SIRS ET of gram-negative bacte-
ria is involved which is received through the intestinal 
mucosa. Increased intestinal permeability in sepsis, se-
rious injury, shock is regarded as a trigger of multiple 
organ failure [8]. The concentration of ET, probably, is 
different in hypo-and hyperergic variant of SIRS.
ET, depending on the concentration may have dif-
ferent effects on the axis hypothalamus - pituitary - 
adrenal and pituitary glands - the thyroid gland [29-
31]. Increase production of T3 (15  4% of children), 
we observed only in hyperergic variant. In the same 
group distinguishing feature of the hormonal profile 
was the high basal level of growth hormone. The 
body’s resistance of septic patient to endogenous (and 
exogenous) growth factor is associated with two fac-
tors: 1) reduction of the receptor expression for the 
growth hormone in the liver cells under the influence 
of cytokines and as a result reduction of the production 
of insulin-like growth factor - IFR1; 2) the presence of 
common signaling way of the growth hormone and 
IL-1β in the liver cells which prevents the realization 
of anabolic effects of GH [32, 33].
High levels of acute phase proteins (not only in com-
parison with the variant “A” but higher than the norm) 
in variant “B” and total plasma protein, we associate 
with the conservation of energy and plastic resources in 
this variant of sepsis and their hormonal support. This 
is confirmed by the absence of low T3 in all children of 
this group, absence of neutropenia and lymphopenia, 
aneosinophilia, higher basal NBT-test and IgM and high- 
er values of LI and IIR. We attribute this as with the pe-
culiarities of the reactivity and with the type of pathogen 
contributing to a different cytokine profile. The presence 
of antimediators by eosinophilic origin ensures detoxi-
fication and allows maintaining a «balance» in the pro-
tease/ antiprotease coagulation link. However, despite 
this fact there is no balance in the cytokine network in 
accordance with clinical data. We tend to agree with the 
characteristic of this SIRS as a «cytokine storm» [34].
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